Autopsy report · NCT04246151

Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients

“No patients enrolled. Identification of patients in allocated timeframe was not feasible.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

Hamilton Health Sciences Corporation

Sponsor type

University, hospital or other

Conditions

Clostridium Difficile Colonization; Clostridium Difficile Diarrhea

Interventions

Vancomycin; Culturelle; Vancomycin Placebo; Probiotic Placebo

Participants

0

Sites

2

Countries

Canada

Trials that died the same way

• Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
  “No eligible patient was enrolled.” (81% match in meaning)
• Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients
  “No patients were enrolled.” (81% match in meaning)
• Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
  “No eligible patients were enrolled.” (81% match in meaning)
• QLESP Block in Hip Surgery
  “No patients enrolled” (80% match in meaning)
• Effects of Atomized Dexmedetomidine on Lung Function in Patients With Chronic Obstructive Pulmonary Disease
  “no patient enrolled.” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.